Profound Medical Corp Stock Current Valuation
| PRN Stock | CAD 10.70 0.14 1.29% |
Valuation analysis of Profound Medical Corp helps investors to measure Profound Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 11th of December 2024, Enterprise Value is likely to grow to about 206.9 M, while Enterprise Value Over EBITDA is likely to drop (6.23). Fundamental drivers impacting Profound Medical's valuation include:
Price Book 7.2465 | Enterprise Value 238.3 M | Enterprise Value Ebitda (7.93) | Price Sales 29.8116 | Enterprise Value Revenue 18.7435 |
Fairly Valued
Today
Please note that Profound Medical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Profound Medical Corp is based on 3 months time horizon. Increasing Profound Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Profound Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Profound Stock. However, Profound Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.7 | Real 11.0 | Hype 10.84 | Naive 10.95 |
The intrinsic value of Profound Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Profound Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Profound Medical Corp helps investors to forecast how Profound stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Profound Medical more accurately as focusing exclusively on Profound Medical's fundamentals will not take into account other important factors: Profound Medical Corp Company Current Valuation Analysis
Profound Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Profound Medical Current Valuation | 238.26 M |
Most of Profound Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Profound Medical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Profound Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Profound Medical is extremely important. It helps to project a fair market value of Profound Stock properly, considering its historical fundamentals such as Current Valuation. Since Profound Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Profound Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Profound Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Profound Medical Corp has a Current Valuation of 238.26 M. This is 98.34% lower than that of the Health Care Equipment & Supplies sector and 96.94% lower than that of the Health Care industry. The current valuation for all Canada stocks is 98.57% higher than that of the company.
Profound Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Profound Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Profound Medical could also be used in its relative valuation, which is a method of valuing Profound Medical by comparing valuation metrics of similar companies.Profound Medical is currently under evaluation in current valuation category among its peers.
Profound Fundamentals
| Return On Equity | -0.9 | ||||
| Return On Asset | -0.45 | ||||
| Operating Margin | (3.17) % | ||||
| Current Valuation | 238.26 M | ||||
| Shares Outstanding | 24.66 M | ||||
| Shares Owned By Insiders | 8.39 % | ||||
| Shares Owned By Institutions | 43.81 % | ||||
| Number Of Shares Shorted | 92.65 K | ||||
| Price To Book | 7.25 X | ||||
| Price To Sales | 29.81 X | ||||
| Revenue | 7.2 M | ||||
| Gross Profit | 3.02 M | ||||
| EBITDA | (25.97 M) | ||||
| Net Income | (28.57 M) | ||||
| Cash And Equivalents | 27.05 M | ||||
| Cash Per Share | 0.25 X | ||||
| Total Debt | 7.94 M | ||||
| Debt To Equity | 60.50 % | ||||
| Current Ratio | 4.65 X | ||||
| Book Value Per Share | 1.26 X | ||||
| Cash Flow From Operations | (22.3 M) | ||||
| Short Ratio | 9.63 X | ||||
| Earnings Per Share | (1.90) X | ||||
| Target Price | 25.03 | ||||
| Number Of Employees | 131 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 267.83 M | ||||
| Total Asset | 43.91 M | ||||
| Retained Earnings | (217.93 M) | ||||
| Working Capital | 35.53 M | ||||
| Net Asset | 43.91 M |
About Profound Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Profound Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Profound Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Profound Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Profound Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Profound Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profound Medical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Profound Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Profound Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Profound Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Profound Medical Corp to buy it.
The correlation of Profound Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Profound Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Profound Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Profound Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.